4.6 Article

Infection-induced lung injury is worsened after renal buffering of hypercapnic acidosis

期刊

CRITICAL CARE MEDICINE
卷 37, 期 11, 页码 2953-2961

出版社

LIPPINCOTT WILLIAMS & WILKINS
DOI: 10.1097/CCM.0b013e3181b028ce

关键词

buffered hypercapnia; acidosis respiratory; Escherichia coli; acute respiratory distress syndrome; infection

资金

  1. Program for Research in Third Level Institutions
  2. Intensive Care Society of Ireland
  3. College of Anaesthetists Ireland
  4. Irish Research Council for Science, Engineering, and Technology

向作者/读者索取更多资源

Objective: Prolonged hypercapnia is commonly encountered during the treatment of acute respiratory distress syndrome and acute respiratory failure attributable to other causes with protective ventilation strategies. In these circumstances, compensatory renal buffering returns pH to normal establishing a condition of buffered hypercapnia. It is also common intensive care practice to correct the pH more rapidly using bicarbonate infusions. Although it is well-established that hypercapnic acidosis has potent anti-inflammatory and protective effects, the effect of buffered hypercapnia on acute lung injury and acute respiratory distress syndrome is unknown. We therefore wished to determine the effects of buffered hypercapnia on acute lung injury induced by endotoxin or Escherichia coli infection in vivo. Design: Prospective, randomized animal study. Setting. University research laboratory. Subjects: Adult male Sprague-Dawley rats. Interventions: We established buffered hypercapnia by exposing rats to a hypercapnic environment for 3 days before the induction of lung injury. Buffered hypercapnia rats (initial pH >7.35, FiCO(2) = 0.05) and normocapnic controls (initial pH >7.35, FiCO(2) = 0.00) were then anesthetized, mechanically ventilated, and lung injury induced by intra-tracheal inoculation of endotoxin (series 1) or Escherichia coli (series 11). Measurements and Main Results: Buffered hypercapnia significantly increased both endotoxin and Escherichia coli-induced lung injury when compared to normocapnic controls, as assessed by arterial oxygenation, lung compliance, pro-inflammatory pulmonary cytokine concentrations, and measurements of structural lung damage. In additional in vitro experiments buffered hypercapnia did not alter neutrophil phagocytosis ability but did impaired epithelial wound healing. Conclusions. Our results demonstrate that infection-induced injury in vivo is worsened after renal buffering of hypercapnic acidosis independently of any changes in tidal volume. These findings have important implications for our understanding of the pathogenesis of infection-induced lung injury during the use protective ventilation strategies that permits buffered hypercapnia and during infective exacerbations of chronic lung diseases associated with sustained hypercapnia. (Crit Care Med 2009; 37: 2953-2961)

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.6
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

Letter Anesthesiology

Airway pressure release ventilation: a survey of UK practice

Louise Rose, Luigi Camporota, Gary H. Mills, John Laffey, Gavin D. Perkins, Manu Shankar-Hari, Tamas Szakmany, Danny McAuley, RELEASE Investigators

BRITISH JOURNAL OF ANAESTHESIA (2023)

Article Medicine, General & Internal

Long-term (180-Day) Outcomes in Critically Ill Patients With COVID-19 in the REMAP-CAP Randomized Clinical Trial

Alisa M. Higgins, Lindsay R. Berry, Elizabeth Lorenzi, Srinivas Murthy, Zoe McQuilten, Paul R. Mouncey, Farah Al-Beidh, Djillali Annane, Yaseen M. Arabi, Abi Beane, Wilma Van Bentum-Puijk, Zahra Bhimani, Marc J. M. Bonten, Charlotte A. Bradbury, Frank M. Brunkhorst, Aiden Burrell, Adrian Buzgau, Meredith Buxton, Walton N. Charles, Matthew Cove, Michelle A. Detry, Lise J. Estcourt, Elizabeth O. Fagbodun, Mark Fitzgerald, Timothy D. Girard, Ewan C. Goligher, Herman Goossens, Rashan Haniffa, Thomas Hills, Christopher M. Horvat, David T. Huang, Nao Ichihara, Francois Lamontagne, John C. Marshall, Daniel F. McAuley, Anna McGlothlin, Shay P. McGuinness, Bryan J. McVerry, Matthew D. Neal, Alistair D. Nichol, Rachael L. Parke, Jane C. Parker, Karen Parry-Billings, Sam E. C. Peters, Luis F. Reyes, Kathryn M. Rowan, Hiroki Saito, Marlene S. Santos, Christina T. Saunders, Ary Serpa-Neto, Christopher W. Seymour, Manu Shankar-Hari, Lucy M. Stronach, Alexis F. Turgeon, Anne M. Turner, Frank L. van de Veerdonk, Ryan Zarychanski, Cameron Green, Roger J. Lewis, Derek C. Angus, Colin J. McArthur, Scott Berry, Lennie P. G. Derde, Anthony C. Gordon, Steve A. Webb, Patrick R. Lawler

Summary: The longer-term effects of therapies for critically ill COVID-19 patients are unknown. In this study, 4869 patients were randomized to receive different interventions, and it was found that treatment with IL-6 receptor antagonists and antiplatelet agents significantly improved survival rates after 180 days. These findings suggest that most therapies have consistent effects over a 6-month period.

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2023)

Article Critical Care Medicine

Extracorporeal membrane oxygenation and Extracorporeal Membrane Oxygenation Cardiopulmonary Resusciation (ECPR) research priorities in Australia: A clinician survey

Mark Dennis, Timothy J. Southwood, Matthew Oliver, Alistair Nichol, Aidan Burrell, Carol Hodgson

Summary: This study conducted a survey among clinicians in Australia and New Zealand and found strong support for further research on optimizing the use of ECMO and ECPR. The results provide a framework for prioritizing future clinical trials and research agendas.

AUSTRALIAN CRITICAL CARE (2023)

Article Critical Care Medicine

Nutrition care processes across hospitalisation in critically ill patients with COVID-19 in Australia: A multicentre prospective observational study

Emma J. Ridley, Lee-anne S. Chapple, Kate Ainscough, Aidan Burrell, Lewis Campbell, Claire Dux, Suzie Ferrie, Kate Fetterplace, Matin Jamei, Victoria King, Ary Serpa Neto, Alistair Nichol, Emma Osland, Eldho Paul, Matthew Summers, Andrea P. Marshall, Andrew Udy

Summary: This study aimed to describe nutrition-related service delivery practices in critically ill patients with COVID-19 admitted to Australian ICUs during the initial pandemic phase. Results showed that approximately half of the patients were seen by a dietitian, with increased malnutrition screening in the ICU associated with higher risk scores and higher likelihood of dietetic consult.

AUSTRALIAN CRITICAL CARE (2023)

Article Critical Care Medicine

Weaning from mechanical ventilation in intensive care units across 50 countries (WEAN SAFE): a multicentre, prospective, observational cohort study

Tai Pham, Leo Heunks, Giacomo Bellani, Fabiana Madotto, Irene Aragao, Gaetan Beduneau, Ewan C. Goligher, Giacomo Grasselli, Jon Henrik Laake, Jordi Mancebo, Oscar Penuelas, Lise Piquilloud, Antonio Pesenti, Hannah Wunsch, Frank van Haren, Laurent Brochard, John G. Laffey

Summary: This study investigated the management and outcomes of weaning from invasive mechanical ventilation in patients requiring at least 2 days of ventilation. The results showed that only 65% of patients were successfully weaned at 90 days. Factors such as delayed initiation of weaning and excessive sedation levels were associated with weaning failure. Understanding these factors could improve the success rate of weaning.

LANCET RESPIRATORY MEDICINE (2023)

Article Chemistry, Medicinal

Differential Effects of Cytokine Versus Hypoxic Preconditioning of Human Mesenchymal Stromal Cells in Pulmonary Sepsis Induced by Antimicrobial-Resistant Klebsiella pneumoniae

Declan Byrnes, Claire H. Masterson, Jack Brady, Senthilkumar Alagesan, Hector E. Gonzalez, Sean D. McCarthy, Juan Fandino, Daniel P. O'Toole, John G. Laffey

Summary: This study investigates the potential of mesenchymal stromal cells (MSCs) for treating pulmonary sepsis caused by antimicrobial-resistant bacterial strains. The results show that pre-conditioning MSCs enhances their therapeutic potential by promoting wound healing, reducing inflammation, preserving metabolic activity, and enhancing bacterial killing. Additionally, the study demonstrates that MSCs pre-activated with cytokines are more effective in attenuating pneumosepsis and improving lung function compared to naive and hypoxia-exposed MSCs.

PHARMACEUTICALS (2023)

Article Critical Care Medicine

ESICM guidelines on acute respiratory distress syndrome: definition, phenotyping and respiratory support strategies

Giacomo Grasselli, Carolyn S. Calfee, Luigi Camporota, Daniele Poole, Marcelo B. P. Amato, Massimo Antonelli, Yaseen M. Arabi, Francesca Baroncelli, Jeremy R. Beitler, Giacomo Bellani, Geoff Bellingan, Bronagh Blackwood, Lieuwe D. J. Bos, Laurent Brochard, Daniel Brodie, Karen E. A. Burns, Alain Combes, Sonia D'Arrigo, Daniel De Backer, Alexandre Demoule, Sharon Einav, Eddy Fan, Niall D. Ferguson, Jean-Pierre Frat, Luciano Gattinoni, Claude Guerin, Margaret S. Herridge, Carol Hodgson, Catherine L. Hough, Samir Jaber, Nicole P. Juffermans, Christian Karagiannidis, Jozef Kesecioglu, Arthur Kwizera, John G. Laffey, Jordi Mancebo, Michael A. Matthay, Daniel F. McAuley, Alain Mercat, Nuala J. Meyer, Marc Moss, Laveena Munshi, Sheila N. Myatra, Michelle Ng Gong, Laurent Papazian, Bhakti K. Patel, Mariangela Pellegrini, Anders Perner, Antonio Pesenti, Lise Piquilloud, Haibo Qiu, Marco Ranieri, Elisabeth Riviello, Arthur S. Slutsky, Renee D. Stapleton, Charlotte Summers, Taylor B. Thompson, Carmen Valente Barbas, Jesus Villar, Lorraine B. Ware, Bjoern Weiss, Fernando G. Zampieri, Elie Azoulay, Maurizio Cecconi

Summary: The aim of these guidelines is to update the 2017 clinical practice guideline (CPG) of the European Society of Intensive Care Medicine (ESICM). The scope of this CPG is limited to adult patients and to non-pharmacological respiratory support strategies across different aspects of acute respiratory distress syndrome (ARDS), including ARDS due to coronavirus disease 2019 (COVID-19). These guidelines were formulated by an international panel of clinical experts, one methodologist and patients' representatives on behalf of the ESICM.

INTENSIVE CARE MEDICINE (2023)

Article Public, Environmental & Occupational Health

Characteristics and outcomes of an international cohort of 600000 hospitalized patients with COVID-19

Christiana Kartsonaki, J. Kenneth Baillie, Noelia Garcia Barrio, Joaquin Baruch, Abigail Beane, Lucille Blumberg, Fernando Bozza, Tessa Broadley, Aidan Burrell, Gail Carson, Barbara Wanjiru Citarella, Andrew Dagens, Emmanuelle A. Dankwa, Christl A. Donnelly, Jake Dunning, Loubna Elotmani, Martina Escher, Nataly Farshait, Jean-Christophe Goffard, Bronner P. Goncalves, Matthew Hall, Madiha Hashmi, Benedict Sim Lim Heng, Antonia Ho, Waasila Jassat, Miguel Pedrera Jimenez, Cedric Laouenan, Samantha Lissauer, Ignacio Martin-Loeches, France Mentre, Laura Merson, Ben Morton, Daniel Munblit, Nikita A. Nekliudov, Alistair D. Nichol, Budha Charan Singh Oinam, David Ong, Prasan Kumar Panda, Michele Petrovic, Mark G. Pritchard, Nagarajan Ramakrishnan, Grazielle Viana Ramos, Claire Roger, Oana Sandulescu, Malcolm G. Semple, Pratima Sharma, Louise Sigfrid, Emily C. Somers, Anca Streinu-Cercel, Fabio Taccone, Pavan Kumar Vecham, Bharath Kumar Tirupakuzhi Vijayaraghavan, Jia Wei, Evert-Jan Wils, Xin Ci Wong, Peter Horby, Amanda Rojek, Piero L. Olliaro, Ali Abbas

Summary: This study analyzed demographic features, treatments, and clinical outcomes of hospitalized COVID-19 patients in 52 countries from January 2020 to January 2022. Age and male sex were associated with a higher risk of death. Symptoms, co-morbidities, and treatments were associated with clinical outcomes. This comprehensive international study provides valuable information for prioritizing treatment for COVID-19 patients at higher risk of death.

INTERNATIONAL JOURNAL OF EPIDEMIOLOGY (2023)

Article Biochemistry & Molecular Biology

Multiple Dosing and Preactivation of Mesenchymal Stromal Cells Enhance Efficacy in Established Pneumonia Induced by Antimicrobial-Resistant Klebsiella pneumoniae in Rodents

Declan Byrnes, Claire H. Masterson, Hector E. Gonzales, Sean D. McCarthy, Daniel P. O'Toole, John G. Laffey

Summary: Antimicrobial-resistant bacteria, such as Klebsiella species, are a common cause of hospital-acquired pneumonia, leading to high mortality and morbidity. Using mesenchymal stem cells (MSCs) to harness the host immune response to these bacteria shows promise in bypassing antimicrobial resistance mechanisms. This study tested the efficacy of repeated doses and preactivated MSCs in attenuating Klebsiella pneumonia-induced pneumonia in rat models. Two doses of MSCs were effective in improving lung function and reducing bacteria and injury, with preactivated MSCs showing superior results. MSC therapy also affected immune cell populations both locally and systemically. Repeated doses of MSCs, particularly preactivated MSCs, enhance their therapeutic potential in treating antimicrobial-resistant Klebsiella pneumonia.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2023)

Review Biochemistry & Molecular Biology

Key Role of Mesenchymal Stromal Cell Interaction with Macrophages in Promoting Repair of Lung Injury

Mirjana Jerkic, Katalin Szaszi, John G. Laffey, Ori Rotstein, Haibo Zhang

Summary: Lung macrophages play a crucial role in pulmonary innate immunity and host defense. The interaction between these macrophages and mesenchymal stromal cells (MSCs) has shown potential in treating inflammatory lung diseases and COVID-19. The lung microenvironment facilitates the secretion of factors by MSCs, leading to polarization of macrophages towards an immunosuppressive M2-like phenotype for tissue repair. In turn, M2-like macrophages can affect the immune regulatory function and tissue reparatory effects of MSCs.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2023)

Article Critical Care Medicine

The association between time of in hospital cardiac arrest and mortality; a retrospective analysis of two UK databases

Peter J. McGuigan, Julia Edwards, Bronagh Blackwood, Paul Dark, James C. Doidge, David A. Harrison, Gareth Kitchen, Izabella Lawson, Alistair D. Nichol, Kathryn M. Rowan, Manu Shankar-Hari, Danny F. McAuley

Summary: This study aimed to report the variation in incidence and outcome of in hospital cardiac arrest (IHCA) based on the hour of occurrence. It was found that IHCA occurred more frequently and had poorer outcomes at night. However, this variation was not present in patients admitted to the intensive care unit (ICU).

RESUSCITATION (2023)

Article Hematology

Thrombotic and hemorrhagic complications of COVID-19 in adults hospitalized in high-income countries compared with those in adults hospitalized in low- and middle-income countries in an international registry

Matthew J. Griffee, Patricia T. Bozza, Luis Felipe Reyes, Devin P. Eddington, Dorothea Rosenberger, Laura Merson, Barbara Wanjiru Citarella, Jonathon P. Fanning, Peta M. A. Alexander, John Fraser, Heidi Dalton

Summary: In this study, the frequency of coagulopathy complications in COVID-19 patients from developing countries (LMICs) was compared to those from high-income countries (HICs), and it was found that complications were more frequent in HICs. Complications were more common in patients receiving advanced treatment, and were associated with increased in-hospital mortality. Moreover, the mortality associated with these complications was higher in LMICs. Therefore, further research is needed to explore timely diagnosis and intervention for coagulation derangements in COVID-19, particularly in limited-resource settings.

RESEARCH AND PRACTICE IN THROMBOSIS AND HAEMOSTASIS (2023)

Article Public, Environmental & Occupational Health

Development of the Consumer Involvement & Engagement Toolkit: a digital resource to build capacity for undertaking patient-centred clinical trials in Australia

Tanya Symons, Janelle Bowden, Anne McKenzie, Julia M. Fallon-Ferguson, Leanne Y. Weekes, James Ansell, Rinki Murphy, Shilpa Jesudason, Manoj Saxena, Alistair Nichol, Nicola Straiton

Summary: This manuscript describes the development of a toolkit to support meaningful consumer involvement in clinical trials in Australia and guide others in creating similar resources. The toolkit aims to enhance consumer participation in prioritizing, designing, and conducting clinical research, and is a comprehensive digital resource derived from best practice literature and international standards.

PUBLIC HEALTH RESEARCH & PRACTICE (2023)

Article Critical Care Medicine

The effect of blood pressure on mortality following out-of-hospital cardiac arrest: a retrospective cohort study of the United Kingdom Intensive Care National Audit and Research Centre database

Peter J. McGuigan, Elisa Giallongo, Bronagh Blackwood, James Doidge, David A. Harrison, Alistair D. Nichol, Kathryn M. Rowan, Manu Shankar-Hari, Markus B. Skrifvars, Karen Thomas, Danny F. McAuley, Peter J. McGuigan

Summary: This retrospective analysis found an association between hypotension and hypertension in the first 24 h in ICU and mortality following OHCA. Patients with a lowest recorded MAP in the range 60-63 mmHg and a highest recorded MAP in the range 95-104 mmHg had the lowest associated mortality. Research into individualized blood pressure targets for survivors following OHCA is needed.

CRITICAL CARE (2023)

Article Medicine, General & Internal

Mild Hypercapnia or Normocapnia after Out-of-Hospital Cardiac Arrest

G. Eastwood, A. D. Nichol, C. Hodgson, R. L. Parke, S. McGuinness, N. Nielsen, S. Bernard, M. B. Skrifvars, D. Stub, F. S. Taccone, J. Archer, D. Kutsogiannis, J. Dankiewicz, G. Lilja, T. Cronberg, H. Kirkegaard, G. Capellier, G. Landoni, J. Horn, T. Olasveengen, Y. Arabi, Y. W. Chia, A. Markota, M. Haenggi, M. P. Wise, A. M. Grejs, S. Christensen, H. Munk-Andersen, A. Granfeldt, G. O. Andersen, E. Qvigstad, A. Flaa, M. Thomas, K. Sweet, J. Bewley, M. Backlund, M. Tiainen, M. Iten, A. Levis, L. Peck, J. Walsham, A. Deane, A. Ghosh, F. Annoni, Y. Chen, D. Knight, E. Lesona, H. Tlayjeh, F. Svensek, P. J. McGuigan, J. Cole, D. Pogson, M. P. Hilty, J. P. During, M. J. Bailey, E. Paul, B. Ady, K. Ainscough, A. Hunt, S. Monahan, T. Trapani, C. Fahey, R. Bellomo

Summary: In patients with coma who were resuscitated after out-of-hospital cardiac arrest, targeted mild hypercapnia did not lead to better neurologic outcomes at 6 months than targeted normocapnia. There were no significant differences in the incidence of death or adverse events between the two groups.

NEW ENGLAND JOURNAL OF MEDICINE (2023)

暂无数据